CoChat
Sign Up
Cited by 13

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Chromosomal location of murine Disabled-2 gene and structural comparison with its human ortholog

Sheng, Zejuan, Smith, Elizabeth R, He, Junqi, Tuppen, Joseph A, Martin, W.David, Dong, Feng B, Xu, Xiang-Xi·2001·Gene
DOI 10.1016/s0378-1119(01)00401-2
Open this paper in CoChat — free account

Abstract

Disabled-2 (Dab2) is one of the two mammalian orthologs of the Drosophila Disabled. The three spliced forms, p96, p93, and p67 of murine Dab2 cDNAs were first isolated as phosphoproteins functioning in the macrophage CSF-1 signal transduction pathway. Subsequently, the involvement of Dab2 in ovarian cancer development has been investigated: Dab2 expression is lost or greatly diminished in breast and ovarian cancers, and gene deletions have been found. Regulation of Disabled-2 expression is also found to be important in development and physiological functions. Structural information of the murine Dab2 gene is essential for studies of transcription regulation and gene function in mouse models. In this study, the mouse Dab2 gene coding sequence was identified and sequenced from three lambda phage clones containing the gene. Two BAC clones of mouse genomic DNA were also used to identify the sequences of the non-coding first exon and promoter. The first exon is separated from the second exon by a large (15 kb) intron. The mouse gene is about 40 kb in size and consists of 15 exons, producing a 3.6 kb message. The translation initiation site resides in the middle of the second exon. The mouse Dab2 gene structure is very similar to that of its human ortholog in exon/intron sizes and promoter sequences. The chromosomal localization of mouse Dab2 was mapped by FISH to chromosome 15A2, a site of syntax with the human 5p12 where human Dab2 gene resides. The information on the mouse Dab2…

Overview

Integrity signals

Registry

Crossref · 10.1016/s0378-1119(01)00401-2

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Dab2 is one of two mammalian orthologs of the Drosophila Disabled (dDab), a family member of the Disabled proteins involved in neurogenesis, oncogenesis, cellular signaling and embryonic development.

    “Subsequent studies indicated Dab2 as one of two mammalian orthologs of the Drosophila Disabled (dDab) [8-11], a family member of the Disabled proteins involved in neurogenesis, oncogenesis, cellular signaling and embryonic development.”

    From Dynamic expression of Dab2 in the mouse embryonic central nervous system (2008) · cites this paper as [11]

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 30

  1. Albertsen, 1996, Sequence, genomic structure and chromosomal assignment of human DOC-2, Genomics, 33, 207, 10.1006/geno.1996.0185 · DOI
  2. Bastien, 1987, The MT family of mouse DNA is made of short interspersed repeated elements, Gene, 57, 81, 10.1016/0378-1119(87)90179-X · DOI
  3. Cho, 2000, Genomic organization and promoter analysis of mouse disabled 2 gene, Biochem. Biophys. Res. Commun., 275, 189, 10.1006/bbrc.2000.3274 · DOI
  4. Cho, 1999, Differential expression of mouse Disabled 2 gene in retinoic acid-treated F9 embryonal carcinoma cells and early mouse embryos, Mol. Cells, 30, 179, 10.1016/S1016-8478(23)13527-8 · DOI
  5. Fazili, 1999, Disabled-2 inactivation is an early step in ovarian tumorigenicity, Oncogene, 18, 3104, 10.1038/sj.onc.1202649 · DOI · Paper page
  6. Fickett, 1997, Eukaryotic promoter recognition, Genome Res., 7, 861, 10.1101/gr.7.9.861 · DOI
  7. Gertler, 1989, Drosophila abl tyrosine kinase in embryonic CNS axons: a role in axonogenesis is revealed through dosage-sensitive interactions with disabled, Cell, 58, 103, 10.1016/0092-8674(89)90407-8 · DOI · Paper page
  8. Gertler, 1993, Dosage-sensitive modifiers of Drosophila abl tyrosine kinase function: prospero, a regulator of axonal outgrowth, and disabled, a novel tyrosine kinase substrate, Genes Develop., 7, 441, 10.1101/gad.7.3.441 · DOI · Paper page
  9. Howell, 1997, Mouse disabled (mDab1): a Src binding protein implicated in neuronal development, EMBO J., 16, 121, 10.1093/emboj/16.1.121 · DOI · Paper page
  10. Howell, 1997, Neuronal position in the developing brain is regulated by mouse Disabled-1, Nature, 389, 733, 10.1038/39607 · DOI · Paper page
  11. Huber, 1998, Multiple Sp1 sites efficiently drive transcription of the TATA-less promoter of the human glypican 3 (GPC3) gene, Gene, 214, 35, 10.1016/S0378-1119(98)00233-9 · DOI
  12. Knudsen, 1999, Promoter2.0: for the recognition of PolII promoter sequences, Bioinformatics, 15, 356, 10.1093/bioinformatics/15.5.356 · DOI
  13. de Lambert, 1998, Cloning of human DAB1 and mapping to chromosome 1p31-p32, Genomics, 53, 246, 10.1006/geno.1998.5523 · DOI
  14. Mok, 1994, Molecular cloning of differentially expressed genes in human epithelial ovarian cancer, Gynecol. Oncol., 52, 247, 10.1006/gyno.1994.1040 · DOI · Paper page
  15. Mok, 1998, DOC-2, a candidate tumor suppressor gene in human epithelial ovarian cancer, Oncogene, 16, 2381, 10.1038/sj.onc.1201769 · DOI · Paper page
  16. Morrisey, 2000, The gene encoding the mitogen-responsive phosphoprotein Dab2 is differentially regulated by GATA-6 and GATA-4 in the visceral endoderm, J. Biol. Chem., 275, 19949, 10.1074/jbc.M001331200 · DOI · Paper page
  17. Prestridge, 1991, SIGNAL SCAN: a computer program that scans DNA sequences for eukaryotic transcriptional elements, Comput. Appl. Biosci., 7, 203
  18. Prestridge, 1995, Prediction of Pol II Promoter sequences using transcription factor binding sites, J. Mol. Biol., 249, 923, 10.1006/jmbi.1995.0349 · DOI
  19. Prestridge, 1996, SIGNAL SCAN 4.0: additional databases and sequence formats, Comput. Appl. Biosci., 12, 157
  20. Quandt, 1995, MatInd and MatInspector – New fast and versatile tools for detection of consensus matches in nucleotide sequence data, Nucleic Acids Res., 23, 4878, 10.1093/nar/23.23.4878 · DOI
  21. Reese, 1995, New neural network algorithms for improved eukaryotic promoter site recognition, Genome Sci. Technol., 1, 45
  22. Schwahn, 1998, p96, a MAPK-related protein, is consistently downregulated during mouse mammary carcinogenesis, Oncogene, 17, 1173, 10.1038/sj.onc.1202038 · DOI · Paper page
  23. Sheng, 2000, Restoration of positioning control by Disabled-2 expression in breast and ovarian tumor cells, Oncogene, 19, 4847, 10.1038/sj.onc.1203853 · DOI
  24. Sheng, 2000, Structure, sequence and promoter analysis of human Disabled-2 gene, Genomics, 70, 381, 10.1006/geno.2000.6383 · DOI
  25. Trommsdorff, 1999, Reeler/Disabled-like disruption of neuronal migration in knockout mice lacking the VLDL receptor and ApoE receptor 2, Cell, 97, 689, 10.1016/S0092-8674(00)80782-5 · DOI · Paper page
  26. Tseng, 1998, Regulation of rat DOC-2 gene during castration-induced rat ventral prostate degeneration and its growth inhibitory function in human prostatic carcinoma cells, Endocrinology, 139, 3542, 10.1210/endo.139.8.6159 · DOI · Paper page
  27. Ware, 1997, Aberrant splicing of a mouse disabled homolog, mdab1, in the scrambler mouse, Neuron, 19, 239, 10.1016/S0896-6273(00)80936-8 · DOI
  28. Xu, 1995, Molecular cloning of a CSF-1 regulated protein with a domain homologous to Drosophila disabled, J. Biol. Chem., 270, 14184, 10.1074/jbc.270.23.14184 · DOI · Paper page
  29. Xu, 1998, Disabled-2 is an SH3 domain binding partner of Grb2, Oncogene, 16, 1561, 10.1038/sj.onc.1201678 · DOI
  30. Zuber, 2000, A genome-wide survey of RAS transformation targets, Nat. Genet., 24, 144, 10.1038/72799 · DOI

Cited by

Sorted by citations

Metadata

Authors
Sheng, Z., Smith, E. R., He, J., Tuppen, J. A., Martin, W. D., Dong, F. B., & Xu, X.-X.
Venue
Gene
Publisher
Elsevier BV
Published
2001-05
Volume
268
Issue
1-2
Pages
31-39
ISSN
0378-1119
DOI
10.1016/s0378-1119(01)00401-2
Cited by
13
References
2
Language
en
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review